Encompass Health director granted 1,634 RSUs

Hayes Cain A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hayes Cain A reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Cain A. Hayes reported receiving an annual grant of 1,634 shares of Encompass Health Common Stock, awarded as restricted stock units under the corporation's 2025 Omnibus Performance Incentive Plan. After this compensation-related award, Hayes directly holds 2,092 shares.

Insider Trade Summary

Grant/Award: 1,634 shares

Grant/Award 1 txn

Insider Hayes Cain A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	1,634	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 2,092 shares (Direct)

Footnotes (1)

1. F1. Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

Key Figures

RSU grant: 1,634 shares Holdings after transaction: 2,092 shares Transaction price: $0.0000 per share

3 metrics

RSU grant 1,634 shares Annual restricted stock unit award under 2025 Omnibus Performance Incentive Plan

Holdings after transaction 2,092 shares Directly held Encompass Health Common Stock after grant

Transaction price $0.0000 per share Reported price for the 1,634-share grant

Key Terms

restricted stock units, 2025 Omnibus Performance Incentive Plan, Form 4, Grant, award, or other acquisition

4 terms

restricted stock units financial

"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2025 Omnibus Performance Incentive Plan financial

"pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Encompass Health (EHC) report for Cain A. Hayes?

Encompass Health reported that director Cain A. Hayes received an award of 1,634 shares of Encompass Health Common Stock. The grant was made as part of his annual equity compensation and increased his directly held position to 2,092 shares.

Was the Encompass Health (EHC) Form 4 transaction a purchase or a grant?

The Form 4 shows a grant, not an open-market purchase. Cain A. Hayes acquired 1,634 shares through an award classified under transaction code A, representing a grant, award, or other acquisition as part of the company’s compensation program.

What price did Cain A. Hayes pay for his Encompass Health (EHC) share grant?

The reported transaction price per share is 0.0000, indicating Hayes did not pay cash for the 1,634 shares. The award represents compensation in the form of restricted stock units under Encompass Health’s 2025 Omnibus Performance Incentive Plan.

How many Encompass Health (EHC) shares does Cain A. Hayes hold after this Form 4?

After the grant of 1,634 shares, Cain A. Hayes directly holds a total of 2,092 Encompass Health Common Stock shares. This figure reflects his position immediately following the reported compensation-related equity award on the stated transaction date.

What plan governed the equity award reported in Encompass Health (EHC) Form 4?

The equity award is described as an annual grant of restricted stock units under Encompass Health’s 2025 Omnibus Performance Incentive Plan. This plan governs the terms, eligibility, and structure of performance-based and other incentive equity awards for eligible participants.

Does the Encompass Health (EHC) Form 4 indicate any share sales by Cain A. Hayes?

The Form 4 does not report any sales by Cain A. Hayes. It shows only one acquisition transaction coded A, representing a grant or award of 1,634 shares, with no dispositions or sell transactions disclosed in the summarized data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 11:41 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hayes Cain A

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	05/07/2026		A		1,634(1)	A	$0	2,092	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

	/s/ Patrick Darby, attorney-in-fact for Cain A. Hayes	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)